Skip to main content
Top
Published in: Cardiology and Therapy 2/2024

Open Access 07-02-2024 | Heart Failure | Original Research

Real-World Heart Failure Burden in Thai Patients

Authors: Panyapat Jiampo, Thidaporn Tangkittikasem, Thanita Boonyapiphat, Vichai Senthong, Artit Torpongpun

Published in: Cardiology and Therapy | Issue 2/2024

Login to get access

Abstract

Introduction

Heart failure (HF) is one of the leading causes of hospitalization worldwide. In Thailand, data on HF burden remains limited. This study aimed to describe comprehensive evidence detailing the HF prevalence, hospital admission rates, in-hospital mortality, and overall mortality rates at the hospital level.

Method

All eligible adult patients’ medical records from 2018 and 2019 were analyzed retrospectively at five hospitals in different regions. The patients were diagnosed with HF, as indicated by the International Classification of Diseases (ICD)-10 code I50. Descriptive statistics were used to examine the hospital burden as well as patients’ clinical and outcome data.

Results

A total of 7384 patients with HF were identified from five tertiary hospitals. Around half of the patients were male. The mean age was 67 years, and the main health insurance scheme was the Universal Coverage Scheme. The prevalence of HF was 0.1% in 2018 and 0.2% in 2019. Heart failure with preserved ejection fraction (HFpEF) was the most common type of HF in both visits, followed by heart failure with reduced ejection fraction (HFrEF) and heart failure with mildly reduced ejection fraction (HFmrEF). The proportion of HF hospitalizations was 1.2% in 2018 and 1.5% in 2019. The proportion of HF rehospitalizations versus hospitalizations in patients with HF was 22.7% in 2018 and 23.9% in 2019. The risk of rehospitalization was highest at 180 days after hospital discharge (87.8%). Among the patients with HF, the proportion of all-cause mortality was 9.1% in 2018 and 8.0% in 2019. Most of the deaths occurred within 30 days after hospitalization.

Conclusion

Our study demonstrated that the burden of HF in terms of hospitalization and in-hospital mortality was notably high when compared to similar studies conducted in Thailand and other countries.
Appendix
Available only for authorised users
Literature
2.
go back to reference Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of HF. Nat Rev Cardiol. 2011;8(1):30–41.CrossRefPubMed Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of HF. Nat Rev Cardiol. 2011;8(1):30–41.CrossRefPubMed
3.
go back to reference Ponikowski P, Anker SD, AlHabib KF, et al. HF: preventing disease and death worldwide. ESC HF. 2014;1(1):4–25. Ponikowski P, Anker SD, AlHabib KF, et al. HF: preventing disease and death worldwide. ESC HF. 2014;1(1):4–25.
7.
go back to reference Shimokawa H, Miura M, Nochioka K, et al. HF as a general pandemic in Asia. Eur J Heart Fail. 2015;17(9):884–92.CrossRefPubMed Shimokawa H, Miura M, Nochioka K, et al. HF as a general pandemic in Asia. Eur J Heart Fail. 2015;17(9):884–92.CrossRefPubMed
8.
go back to reference Roger VL, Weston SA, Redfield MM, et al. Trends in HF incidence and survival in a community-based population. JAMA. 2004;292(3):344–50.CrossRefPubMed Roger VL, Weston SA, Redfield MM, et al. Trends in HF incidence and survival in a community-based population. JAMA. 2004;292(3):344–50.CrossRefPubMed
9.
go back to reference Tavazzi L, Senni M, Metra M, et al. Multicenter prospective observational study on acute and chronic HF: one-year follow-up results of IN-HF (Italian Network on HF) outcome registry. Circ Heart Fail. 2013;6(3):473–81.CrossRefPubMed Tavazzi L, Senni M, Metra M, et al. Multicenter prospective observational study on acute and chronic HF: one-year follow-up results of IN-HF (Italian Network on HF) outcome registry. Circ Heart Fail. 2013;6(3):473–81.CrossRefPubMed
10.
go back to reference Jhund PS, Macintyre K, Simpson CR, et al. Long-term trends in first hospitalization for HF and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119(4):515–23. Jhund PS, Macintyre K, Simpson CR, et al. Long-term trends in first hospitalization for HF and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119(4):515–23.
11.
go back to reference Laothavorn P, Hengrussamee K, Kanjanavanit R, et al. Thai Acute Decompensated HF Registry (Thai ADHERE). CVD Prev Control. 2010;5(3):89–95. Laothavorn P, Hengrussamee K, Kanjanavanit R, et al. Thai Acute Decompensated HF Registry (Thai ADHERE). CVD Prev Control. 2010;5(3):89–95.
12.
go back to reference Janwanishstaporn S, Karaketklang K, Krittayaphong R. National trend in HF hospitalization and outcome under public health insurance system in Thailand 2008–2013. BMC Cardiovasc Disord. 2022;22(1):203.CrossRefPubMedPubMedCentral Janwanishstaporn S, Karaketklang K, Krittayaphong R. National trend in HF hospitalization and outcome under public health insurance system in Thailand 2008–2013. BMC Cardiovasc Disord. 2022;22(1):203.CrossRefPubMedPubMedCentral
13.
go back to reference Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46–215.PubMed Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46–215.PubMed
14.
go back to reference Neumann T, Biermann J, Erbel R, et al. HF: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int. 2009;106(16):269–75.PubMedPubMedCentral Neumann T, Biermann J, Erbel R, et al. HF: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int. 2009;106(16):269–75.PubMedPubMedCentral
15.
go back to reference Savarese G, Becher PM, Lund LH, et al. Global burden of HF: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–87.CrossRefPubMed Savarese G, Becher PM, Lund LH, et al. Global burden of HF: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–87.CrossRefPubMed
16.
go back to reference MacDonald MR, Tay WT, Teng TK, et al. Regional variation of mortality in HF with reduced and preserved ejection fraction across Asia: outcomes in the ASIAN-HF registry. J Am Heart Assoc. 2020;9(1):e012199.CrossRefPubMed MacDonald MR, Tay WT, Teng TK, et al. Regional variation of mortality in HF with reduced and preserved ejection fraction across Asia: outcomes in the ASIAN-HF registry. J Am Heart Assoc. 2020;9(1):e012199.CrossRefPubMed
17.
go back to reference Shiga T, Suzuki A, Haruta S, et al. Clinical characteristics of hospitalized HF patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. 2019;6(3):475–86.CrossRefPubMedPubMedCentral Shiga T, Suzuki A, Haruta S, et al. Clinical characteristics of hospitalized HF patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. 2019;6(3):475–86.CrossRefPubMedPubMedCentral
18.
go back to reference Hao G, Wang X, Chen Z, et al. Prevalence of HF and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail. 2019;21(11):1329–37.CrossRefPubMed Hao G, Wang X, Chen Z, et al. Prevalence of HF and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail. 2019;21(11):1329–37.CrossRefPubMed
19.
go back to reference Honma M, Tanaka F, Sato K, et al. Sex-specific temporal trends in the incidence and prevalence of hospitalized patients with preserved versus reduced left ventricular ejection fraction HF: a Japanese community-wide study. Int J Cardiol Heart Vasc. 2015;9:15–21.PubMedPubMedCentral Honma M, Tanaka F, Sato K, et al. Sex-specific temporal trends in the incidence and prevalence of hospitalized patients with preserved versus reduced left ventricular ejection fraction HF: a Japanese community-wide study. Int J Cardiol Heart Vasc. 2015;9:15–21.PubMedPubMedCentral
20.
go back to reference Tankumpuan T, Sindhu S, Perrin N, et al. A multi-site Thailand HF Snapshot Study. Heart Lung Circ. 2022;31(1):85–94.CrossRefPubMed Tankumpuan T, Sindhu S, Perrin N, et al. A multi-site Thailand HF Snapshot Study. Heart Lung Circ. 2022;31(1):85–94.CrossRefPubMed
21.
go back to reference Youn YJ, Yoo B-S, Lee J-W, et al. Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean Heart Failure Registry. Circ J. 2012;76(5):1151–8.CrossRefPubMed Youn YJ, Yoo B-S, Lee J-W, et al. Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean Heart Failure Registry. Circ J. 2012;76(5):1151–8.CrossRefPubMed
22.
go back to reference Zhang Y, Zhang J, Butler J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for HF in China: results from the China HF (China-HF) registry. J Card Fail. 2017;23(12):868–75.CrossRefPubMed Zhang Y, Zhang J, Butler J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for HF in China: results from the China HF (China-HF) registry. J Card Fail. 2017;23(12):868–75.CrossRefPubMed
23.
go back to reference Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, et al. Characteristics and outcomes of hospitalized patients with HF and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of HF in Cardiology (JCARE-CARD). Circ J. 2009;73(10):1893–900. Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, et al. Characteristics and outcomes of hospitalized patients with HF and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of HF in Cardiology (JCARE-CARD). Circ J. 2009;73(10):1893–900.
24.
go back to reference Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic HF and preserved, mid-range and reduced ejection fraction: an analysis of the ESC HF Long-Term Registry. Eur J Heart Fail. 2017;19(12):1574–85.CrossRefPubMed Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic HF and preserved, mid-range and reduced ejection fraction: an analysis of the ESC HF Long-Term Registry. Eur J Heart Fail. 2017;19(12):1574–85.CrossRefPubMed
Metadata
Title
Real-World Heart Failure Burden in Thai Patients
Authors
Panyapat Jiampo
Thidaporn Tangkittikasem
Thanita Boonyapiphat
Vichai Senthong
Artit Torpongpun
Publication date
07-02-2024
Publisher
Springer Healthcare
Keyword
Heart Failure
Published in
Cardiology and Therapy / Issue 2/2024
Print ISSN: 2193-8261
Electronic ISSN: 2193-6544
DOI
https://doi.org/10.1007/s40119-024-00355-8

Other articles of this Issue 2/2024

Cardiology and Therapy 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.